[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-451923-105":59,"doc-detail-451923-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-future-of-vesicular-drug-delivery-transferosomes-in-therapeutic-advancement-applications-innovations-and-challenges","The future of vesicular drug delivery - Transferosomes in therapeutic advancement - applications, innovations and challenges","","Transferosomes are an ultra-deformable vesicular drug delivery system designed to overcome limitations of conventional transdermal approaches. Their lipid bilayer architecture enables barrier disruption by diffusion through the stratum corneum, supporting transport of both small molecules and macromolecules such as proteins and peptides. This review covers core structural components, preparation routes, and characterization methods, highlighting trans-epidermal hydration-driven skin penetration, broad therapeutic uses, and clinical translation barriers including stability, scalability, formulation complexity, skin variability, and toxicity. It also surveys innovations and future directions.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-future-of-vesicular-drug-delivery-transferosomes-in-therapeutic-advancement-applications-innovations-and-challenges/451923/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-future-of-vesicular-drug-delivery-transferosomes-in-therapeutic-advancement-applications-innovations-and-challenges/451923.png","ImageObject",300,407,{"name":92,"@type":93},"Franzy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-30",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem do transferosomes aim to solve in transdermal drug delivery?","Question",{"text":112,"@type":113},"Transferosomes are designed to address key limitations of traditional transdermal systems by enabling improved transport across biological barriers, particularly the stratum corneum.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do transferosomes penetrate skin according to the review?",{"text":117,"@type":113},"Skin penetration is initiated by a trans-epidermal hydration gradient, which drives the transferosome mechanism and supports barrier disruption for drug transport.",{"name":119,"@type":110,"acceptedAnswer":120},"What benefits do transferosomes offer compared with standard formulations?",{"text":121,"@type":113},"They can enhance bioavailability, reduce systemic effects, support regional action, and improve patient adherence, while enabling delivery of diverse therapeutics including small and large biomolecules.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},451923,1790796997,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},2336478945519,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Medhi etal. BioMedical Engineering OnLine (2026) 25:1  \n[https://doi.org/10.1186/s12938-025-01490-6](https://doi.org/10.1186/s12938-025-01490-6)  \nBioMedical Engineering OnLine  \nREVIEW Open Access  \nThe future of vesicular drug delivery:  \ntransferosomes in therapeutic advancement—applications, innovations and challenges  \nJharna Medhi 1 , ChandrashekarThalluri1*, Mallikarjun Vasam2 and Sarad Pawar Naik Bukke3*  \n*Correspondence: [chandu6716@gmail.com](chandu6716@gmail.com); [drsaradpawar@kiu.ac.ug](drsaradpawar@kiu.ac.ug)  \n1 Faculty of Pharmaceutical Science, Assam Down  \nTown University (AdtU), Guwahati 781026, Assam, India  \n2 Department of Pharmaceutics, Omega College of Pharmacy, Osmania University, Edulabad, Ghatkesar, Hyderabad, Telangana 501301, India  \n3 Department of Pharmaceuticsand Pharmaceutical Technology, Kampala International University, Western Campus, P. O. Box 71, Ishaka, Bushenyi, Uganda  \nAbstract  \nTransferosomes represent a novel vesicular drug delivery system developed to overcome the limitations of traditional transdermal systems. These ultra-deformable lipid bilayers facilitate barrier disruption via diffusion across the stratum corneum and transport both small molecules and macromolecules such as proteins and peptides. This review discusses the structural components of transferosomes, methods of preparation and methods of characterization, with an emphasis on the unique mechanism of skin penetration that is initiated by a trans-epidermal hydration gradient. The potential applications for transferosomes span a wide range of therapeutics including antioxidants, corticosteroids, anticancer agents, NSAIDs and biomolecules, such as insulin and interferons. Transferosomes offer many benefits such as enhanced bioavailability, reduced systemic effects, regional action, and improved patient adherence. However, the leap to clinical applications has been challenging due to barriers related to stability, scalability, complex formulations, variability in skin biology and toxicity. Recent innovations—hybrid vesicular systems, polymer-coated transferosomes and lyophilizationto improve stability or laden transferosomes with topical cosmeceuticals and neurotherapeutics—are examples of a more novel therapeutic approach to help patients. Future directions may involve stimuli-responsive systems, buccal and intranasal delivery, and microneedle arrays or a personalized medicine model. In sum, transferosomes represent a flexible nanocarrier platform that has the potential to change transdermal and mucosal drug delivery through an integrated approach between pharmaceutical and biomedical applications.  \nKeywords: Transferosomes, Vesicular drug delivery, Transdermal therapy, Bioavailability, Nanocarriers  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nMedhi etal. BioMedical Engineering OnLine (2026) 25:1 Page 2 of 25  \nGraphical Abstra","cbCaijOeXWtwwH00","https://ap.wps.com/l/cbCaijOeXWtwwH00","pdf",2417595,25,"English","# Introduction\n## Transferosomes as a vesicular carrier\n# Abstract\n## Mechanism and penetration concept\n## Applications and therapeutic scope\n## Benefits and clinical translation challenges\n# Keywords","[{\"question\":\"What problem do transferosomes aim to solve in transdermal drug delivery?\",\"answer\":\"Transferosomes are designed to address key limitations of traditional transdermal systems by enabling improved transport across biological barriers, particularly the stratum corneum.\"},{\"question\":\"How do transferosomes penetrate skin according to the review?\",\"answer\":\"Skin penetration is initiated by a trans-epidermal hydration gradient, which drives the transferosome mechanism and supports barrier disruption for drug transport.\"},{\"question\":\"What benefits do transferosomes offer compared with standard formulations?\",\"answer\":\"They can enhance bioavailability, reduce systemic effects, support regional action, and improve patient adherence, while enabling delivery of diverse therapeutics including small and large biomolecules.\"}]","The future of vesicular drug delivery - Transferosomes in therapeutic advancement - applications, innovations and challenges | PDF",1790736162,63]